Fortrea Holdings Inc. (FTRE) - Stock Analysis
Last updated: Jan 13, 2026
Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Fortrea displays strong operational momentum with raised revenue and backlog, cost savings, debt reductions, and a significant 50% rally in 3 weeks; however, margin compression, leverage, legal risk, and overextension temper conviction, requiring active risk management.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Positive EBITDA ⢠Strong free cash ⢠High leverage FTRE shows improving operating cash generationâpositive quarterly EBITDA and strong free cash flowâyet faces acute leverage and liquidity strain from high debt and sharply reduced equity, keeping profitability negative and raising impairment risk.
Price Behavior
Key Price Behavior Insights: ⢠Steady ascent ⢠Higher lows ⢠LateâDec consolidation Support Level: $16.60 Resistance Level: $17.90 Over the last month FTRE climbed from about $15.72 to $17.39, showing cautious bullish momentum with support near $16.60 and resistance around $17.90, though recent consolidation raises breakout/pullback risk.
Sentiment & News
Key News Insights: ⢠Conference appearances ⢠Share price jump ⢠Earnings upgrades Fortrea's prominent J.P. Morgan appearances plus executive presentations and attendant market reaction (5.5% stock rise, heavy volume and earnings upgrades) signal rising investor interest and value appeal heading into 2026.
AI Summary
Fortrea has shifted from a pure CDMO growth story to a cashâflow and operationalâdiscipline turnaround where investment success depends on converting its >$7.6B backlog into marginâaccretive revenue and sustaining positive free cash flow to materially deârisk high leverage. Monitor quarterly FCF, backlog conversion margins and nearâterm liquidity closelyâany missed quarter, major customer loss, or break below $16.60 would likely trigger a rapid downside repricing.
Description
Fortrea Holdings Inc. is a contract research organization that provides development services for biopharmaceuticals and medical devices globally. Its operations are organized into Clinical Services, covering clinical pharmacology and the spectrum of clinical development, and Enabling Services, which supplies patient access, trial technology, randomization and drug supply support. The company delivers these capabilities through full-service, functional service provider and hybrid models and also offers phase IâIV trial management and post-approval support; it was incorporated in 2023 and is based in Durham, North Carolina.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Dec 4 | Dec 11 | FTRE | Fortrea Holdings Inc. | Fortrea displays strong operational momentum with raised revenue and backlog, cost savings, debt reductions, and a significant 50% rally in 3 weeks; however, margin compression, leverage, legal risk, and overextension temper conviction, requiring active risk management. | Closed | +7.2% |